What happens when you stop taking a GLP-1 medication
(54) found that administering GIPR antagonist to healthy humans reduced postprandial insulin secretion and increased glucose excursions more than administering GLP-1R antagonist (GLP-1RA), indicating that endogenous GIP may play a more significant role in stimulating insulin secretion and reducing postprandial plasma glucose excursions compared to endogenous GLP-1
Jun 03, 2024 5 min read 10001 views Hey everyone
(3) Comparison: The control group interventions included placebo, CPAP, or other antihyperglycemic medications, with no restrictions on basic therapy like limited caloric intake and exercise regimens
Doses dont need to be adjusted for age, though older skin may show effects more readily on some endpoints
Inflammation causes the bodys immune cells to release cytokines and chemokines to recruit other immune cells to the site of oxidative stress (Chatterjee, 2016)